Navigation Links
Experimental Biology and Medicine announces expansion into Asia, opens new office
Date:1/4/2008

onsibilities of Professor Lei and the Asian EBM office will be increasing the visibility of EBM and SEBM throughout the Asia Pacific scientific and academic communities. All of the new Asian members of the EBM Editorial Board will play important roles in educating the Asia Pacific scientific community to the value of SEBM membership and publishing their work in Experimental Biology and Medicine. Professor Lei, and his assistant, will also assist Asian authors in crafting manuscripts that have the highest probability of success.

NCKU is one of the largest, oldest, and most prestigious universities in Taiwan. It has 9 colleges, spanning engineering to the social sciences and 22,000 students. It has a powerful College of Medicine which will be the home of our new EBM Asian office. Dr. Charles Lin, Dean of the College of Medicine at NCKU, said the following concerning the establishment of the Asian EBM office at NCKU Medical Center: By establishing its first Asian Office, the Society of Experimental Biology and Medicine has built a bridge to the scientific society in Asia and a highway of sharing ideas, news and discovery of health science.

Dr. Goodman stated The establishment of our Asian Editor Professor Lei, and the Asian EBM office, is the first step in our globalization plan for EBM and SEBM. We have begun the process of developing a similar Editor position and office in Europe. In discussing the impact of these announcements upon EBM and the SEBM Dr. Burt Sobel, President of SEBM, stated "Under the vigorous and creative leadership of Dr. Steven R Goodman, the Editor-in Chief of Experimental Biology and Medicine, the journal of the Society of Experimental Biology and Medicine, the scope of the journal and of the society itself is expanding profoundly. Two seminal events give credence to the progress being made, namely the appointment by Dr. Goodman of Dr. Lei Huan-Yao as the first Asian Editor for the journal coinciding with the opening of an As
'/>"/>

Contact: Felice O'Grady
sebm@inch.com
201-291-9080
Society for Experimental Biology and Medicine
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
2. Experimental Biology 2008 meets in San Diego April 5-9
3. Insects giant leap reconstructed by founder of sociobiology
4. Tips from the Journals of the American Society for Microbiology
5. New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings
6. Molecular Biology of the Cell celebrates 25 years of publication
7. World class in Systems Biology is the aim
8. Evolutionary biology research on plant shows significance of maternal effects
9. BioMed Central launches Biology Image Library
10. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
11. New partnership offers outsourced R&D in membrane biology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Biology and Medicine announces expansion into Asia, opens new office
(Date:7/23/2014)... using tissue samples cultured from cystic fibrosis patients, scientists ... Marsico Lung Institute have shown that a new CF ... CF drug. , The finding, published today in the ... mutant CFTR protein becomes unstable and loses its ability ... two drugs. The research offers several insights into how ...
(Date:7/23/2014)... , , , , ... , , , , ... extend healthy lifespan. The idea, they argue, would be to target the... , , ... , , , , , ... , , , , , , , Medicine focuses almost ...
(Date:7/23/2014)... Roughly 780 million people around the world have no ... Health Organization (WHO), 3.4 million people die from water-related ... the goal of making a contribution to solving this ... Wendelin Stark, head of the Functional Materials Laboratory, the ... developing a prototype. , "What makes our DrinkPure filter ...
Breaking Biology News(10 mins):UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5ETH student develops filter for clean water around the world 2
... Boston, MA (Jan. 18, 2012) The National ... Research Institute, a subsidiary of Mass. Eye and Ear, ... understand the origins of eye allergies (NEI Grant Number ... principal investigator for the project formally entitled "Cellular and ...
... new approach to motion capture technology is offering fresh ... general. Researchers studied three types of tennis serves, ... which creates the highest potential for shoulder injury. ... Annals of Biomedical Engineering , could aid sports training ...
... of microbiologists led by Indiana University researchers has identified a ... single end or pole of the cell instead of uniform, ... that could have implications in the development of new antibacterial ... bacteria such as Escherichia coli and Bacillus ...
Cached Biology News:Markerless motion capture offers a new angle on tennis injuries 2Markerless motion capture offers a new angle on tennis injuries 3Markerless motion capture offers a new angle on tennis injuries 4Polar growth at the bacterial scale reveals potential new targets for antibiotic therapy 2Polar growth at the bacterial scale reveals potential new targets for antibiotic therapy 3
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
(Date:7/23/2014)... , July 23, 2014 ... ), the global specialty biopharmaceutical company, and ArmaGen, ... a worldwide licensing and collaboration agreement for AGT-182, ... potential treatment of both the central nervous system ... syndrome (MPS II). This collaboration strengthens Shire,s rare ...
(Date:7/23/2014)... N.J. (PRWEB) July 23, 2014 ... Comprehensive Cancer Center has joined its Strategic Alliance ... Strategic Alliance Partnership program, UNC Lineberger will have ... to raise awareness of its cutting-edge research initiatives, ... from UNC Lineberger will work with OncLive to ...
(Date:7/22/2014)... 22, 2014 The Board of Directors of BD ... declared a quarterly dividend of 54.5 cents per common share ... September 9, 2014. The indicated annual dividend rate is $2.18 ... is a leading medical technology company that partners with customers ... and evolving health needs. Our innovative solutions are focused on ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
... 3 ,HemoGenix(R) and ORF Genetics announce the collaboration ... for use in all HALO(R),Assay Kits and HALO(R) ... cells is detected. , ... of growth factors and cytokines using,barley seed as ...
... , QUEBEC CITY, Dec. ... AEZS ; TSX: AEZ), a global biopharmaceutical company focused ... completed the transaction under the previously announced purchase and ... relating to AEterna Zentaris, rights to royalties on future ...
... announces the exclusive licensing of DxS Scorpions™ technology to test for ... and targeted control of contaminant microbes can increase profitability. , ... ... ETS has had the exclusive license to use this technology in ...
Cached Biology Technology:HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 2HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 3AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 2AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 3ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry 2
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... Serotec STAR3000 HISTAR detection systems ... to be used with species specific ... in tissue specimens. Visualisation is accomplished ... that utilises novel polymer labelling technology. ...
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme...
... AmpliTaq DNA Polymerase is ... the PCR process, a testimony to its ... activity profile makes it ideal for PCR ... to guarantee reproducible results. ,, AmpliTaq ...
Biology Products: